Recent News for ITRM - Iterum Therapeutics plc

Date Title
May 31 Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections
Back to the Main ITRM Page...